GLP-1s, Ozempic, and the Body: What a Trauma-Informed Trainer and Therapist Wants You to Know

Woman looking thoughtful representing the psychological experience of body change during GLP-1 therapy and the need for trauma-informed support

Everyone is talking about what GLP-1 medications do to the body physically. The weight loss numbers. The nausea. The muscle loss. The "Ozempic face." What almost nobody is talking about is what happens to your relationship with your body during and after significant weight change, and why that conversation matters just as much as the clinical one.

I am not here to tell you whether to take a GLP-1. That decision belongs between you and your doctor, full stop. What I can offer, as both a licensed therapist and a certified trauma-informed personal trainer, is a perspective on the piece that the medical conversation tends to skip: the psychological and somatic experience of living in a body that is changing rapidly, and what support actually looks like in that context.

What GLP-1s Are and Why the Conversation Is So Charged

GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and others, were originally developed to treat type 2 diabetes. They work by mimicking a hormone that regulates appetite and blood sugar, producing significant weight loss in many users by suppressing hunger and slowing gastric emptying.

Their cultural moment has been extraordinary. As one analysis noted, no medication since Viagra in the 1990s has generated as much public attention as these drugs. They have reshaped conversations about weight, health, bodies, and responsibility in ways that are still unfolding.

The conversation is charged because bodies are charged. Weight has never been just a physical topic. For most of the women I work with, their relationship with their body, including their relationship with their size, has been shaped by decades of external messaging, internalized shame, dieting culture, fitness culture, and the complicated intersection of identity and appearance. A medication that changes the body quickly does not change any of that history. It just adds a new chapter to it.

The Physical Picture: What the Research Says About Muscle Loss

Here is the piece that I think deserves significantly more attention than it is currently getting in popular coverage of GLP-1s.

Weight loss on GLP-1 medications includes fat loss, but it also includes muscle loss. Research suggests that muscle loss accounts for 25 to 39 percent of total weight lost on GLP-1 agonists across 36 to 72 weeks of treatment. A 2024 review confirmed that reduced exercise tolerance was the strongest correlate of greater lean body mass loss in real-world GLP-1 users.

Muscle loss matters for reasons that go well beyond appearance. Muscle tissue burns more energy at rest than fat does, meaning that significant muscle loss can reduce resting metabolic rate and make long-term weight maintenance harder once medication is reduced or stopped. Muscle mass is also directly tied to strength, balance, bone density, and physical function across the lifespan.

A 2024 clinical study found that people who combined GLP-1 medications with regular exercise kept weight off significantly better and regained less weight when they stopped taking GLP-1s compared to those who didn't exercise. A 2025 review published in Obesity Reviews, examining strategies for minimizing muscle loss during GLP-1 treatment, concluded that structured resistance exercise combined with adequate protein intake has significant potential to preserve lean mass and offset the muscle changes typically seen with these medications.

This is where trauma-informed personal training becomes directly relevant, not as an add-on or a wellness gesture, but as a clinically meaningful component of a complete approach to GLP-1 use.

Woman doing resistance band training at home representing muscle preservation during GLP-1 therapy with a trauma-informed personal trainer

What the Physical Conversation Is Missing

Here is the part that my dual training as a therapist and personal trainer makes me particularly attentive to.

A 2025 study found that people interested in using GLP-1s reported greater body shame, body surveillance, weight concerns, and anti-fat bias, as well as lower body appreciation and body neutrality. That profile tells us something important: many people who pursue GLP-1s are doing so from a place of significant disconnection from and dissatisfaction with their bodies. The medication can produce physical change. It cannot, on its own, change what a person believes about themselves or how they inhabit their body.

Decades of research demonstrate that reductions in weight do not reliably translate into a healthier psychological relationship with the body. A 2024 study also found that taking weight loss injections may actually lead to further psychological distress in some users, centered around body weight obsession. The expectation that a changed body will produce a changed sense of self is understandable, and it is also consistently unsupported by the evidence.

As Charlotte Markey, author of a 2025 study on GLP-1s and body image, noted: "Once the excitement about the drugs dies down, we're likely to be in the same position we've always been in, which is that to be comfortable in your own skin, to have a positive sense of your body, you have to do more internal work than external work."

That is the sentence I want every person considering or currently using a GLP-1 to sit with for a moment.

The Body Relationship Layer Nobody Is Addressing

I work with women who have spent years at war with their bodies. Women who have tried every program, tracked every macro, pushed through every plateau, and still lie awake feeling like their body is something to be managed rather than inhabited. For many of them, the appeal of a GLP-1 is not just the weight loss. It is the relief of finally having something that works after years of feeling like they were the problem.

I understand that appeal completely. And I also know, from both the research and from the clinical side of this work, that the body relationship does not automatically update when the body does. You can lose significant weight and still feel disconnected, still feel like you are being watched, still feel like your body is something to apologize for. The nervous system does not reorganize itself around a changed number on the scale.

What actually shifts the body relationship is somatic work: learning to notice sensation, to be present in the body during movement, to build trust with your physical self rather than continue to treat it as an adversary. This is work that happens alongside any external change, not as a result of it.

Woman in quiet somatic awareness representing body image healing and trauma-informed therapy in Gaithersburg Maryland

What Movement Can Do That Medication Cannot

If you are currently taking a GLP-1 or considering it, here is what I would want you to know about movement in that context.

Resistance training is not optional when it comes to preserving what matters most about your physical health on these medications. The research is clear that structured strength training, even bodyweight and resistance band work, done two to three times per week, significantly reduces muscle loss during GLP-1 therapy. It also supports bone density, metabolic health, and the kind of functional strength that determines how you move through daily life now and in the years ahead.

But the kind of movement I am describing is not the same as the kind that is driven by body shame or the urgency to maximize weight loss. Movement that comes from that place tends to be unsustainable, especially when appetite suppression from the medication is making you feel physically different than you are used to. The approach I use with clients, which starts with nervous system state and builds from there, tends to be both more sustainable and more integrative. You are building a relationship with your body, not managing an outcome.

For women with complicated histories around exercise and body image, starting or restarting a movement practice during a period of significant physical change is not small. It requires the right kind of support. A trainer who understands the psychological dimensions of this moment is not a luxury. It is a meaningful part of getting the most out of a significant medical decision.

A Note on Mental Health

The mental health picture around GLP-1 use is more complicated than the popular coverage reflects. A large 2024 study published in Scientific Reports found that people with obesity who were on GLP-1s had a slightly elevated risk of anxiety and suicidal behavior compared with controls, and almost double the risk of major depression.

I am not citing these findings to alarm anyone. The research in this area is still early and the picture is complex. What I am saying is that the psychological experience of being on a GLP-1 deserves professional attention, not just monitoring for physical side effects. If you are experiencing mood changes, increased anxiety, or emotional dysregulation while on a GLP-1, please bring that to both your prescribing provider and a mental health professional. That intersection is exactly what trauma-informed care is designed to address.


Frequently Asked Questions About GLP-1s, Exercise, and Body Image

If you are navigating a significant change in your relationship with your body and want support that addresses both the physical and psychological dimensions, the free consultation is a low-pressure conversation about what that could look like. No pitch, no pressure.

About Meagé: Meagé Clements is a licensed clinical social worker and certified trauma-informed personal trainer based in Gaithersburg, Maryland. She offers trauma-informed therapy virtually throughout Maryland, DC, and Virginia, and trauma-informed personal training virtually worldwide and in person in the DMV. As featured in Oprah Daily.

Next
Next

High-Functioning Anxiety: What It Is, Why It's Exhausting, and Why the Gym Alone Won't Fix It